MDG Target 8.E gap analysis. Dr Hans Hogerzeil Director, Department of Essential Medicines and Pharmaceutical Policies, World Health Organization October 2008. Access to medicines in the MDGs.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Dr Hans Hogerzeil
Director, Department of Essential Medicines and Pharmaceutical Policies, World Health Organization
Target 8.E: In cooperation with pharmaceutical companies, provide access to affordable essential drugs in developing countries
Indicator 8.13. Proportion of Population with Access to Affordable, Essential Drugs on a Sustainable Basis
Recognition of essential medicines in national constitutions
Recently updated National Medicines Policies
Recently updated National Essential Medicines List
Generic substitution policies
Public expenditure on medicines
Increased financial support and differential pricing can have a dramatic impact on medicine availabilityAvailability of Artemether/lumefantrine 20/120 mg in Kenya
Global Fund grant start date (02/2006)